Topoisomerase I (Top1) is a ubiquitous enzyme that removes DNA supercoiling generated during transcription and replication. Top1 can be trapped on DNA as cleavage complexes by the anticancer drugs referred to as Top1 inhibitors as well as by alterations of the DNA structure. We reported recently that Top1 cleavage complexes (Top1cc) are trapped during apoptosis induced by arsenic trioxide and staurosporine. In the present study, we generalize the occurrence of apoptotic Top1cc in response to anticancer drugs, which by themselves do not directly interact with Top1: the topoisomerase II inhibitors etoposide, doxorubicin, and amsacrine, and the tubulin inhibitors vinblastine and Taxol. In all cases, the Top1cc form in the early phase of apoptosis and persist throughout the apoptotic process. Their formation is prevented by the caspase inhibitor benzyloxycarbonyl-Val-Ala-DLAsp(OMe)-fluoromethylketone and the antioxidant N-acetyl-L-cysteine. We propose that the trapping of Top1cc is a general process of programmed cell death, which is caused by alterations of the DNA structure (oxidized bases and strand breaks) induced by caspases and reactive oxygen species. [Mol Cancer Ther 2006; 5(12):3139 -44] 
Introduction
Topoisomerase I (Top1) is an essential enzyme in higher eukaryotes as it removes DNA supercoiling generated during transcription and replication (1 -3) . Top1 relaxes DNA supercoiling by forming DNA single-strand breaks that are produced as Top1 forms a covalent bond between its active site tyrosine (Y723) and a 3 ¶-DNA phosphate.
These Top1-linked breaks allow controlled rotation of the broken DNA around the intact strand (2) . Immediately after the DNA is relaxed, Top1 spontaneously religates the breaks and restores intact duplex DNA. Under normal conditions, the covalent Top1-cleaved DNA intermediates, referred to as Top1 cleavage complexes (Top1cc), are constitutively transient and almost undetectable because the DNA religation (closing) step is much faster than the DNA cleavage (nicking) step. A variety of common DNA alterations, including base oxidation, methylation, mismatches, carcinogenic adducts, abasic sites, and strand breaks, can trap Top1cc by misaligning the DNA ends within the Top1cc and preventing DNA religation (4, 5) . The alkaloid camptothecin and its therapeutic derivatives topotecan and irinotecan also trap Top1 by intercalating specifically inside the Top1cc (2, 6) .
Recently, we and others showed the stabilization of Top1cc in cells undergoing apoptosis (7 -10) . These apoptotic Top1cc have been detected in various human cell types exposed to arsenic trioxide (10) , staurosporine (8) , or UV irradiation (7) . The Top1cc formed during apoptosis likely participate in the cell death program because downregulation of Top1 by small interfering RNA reduces apoptotic DNA fragmentation induced by arsenic trioxide (10) and staurosporine (8) . In the present study, we asked whether the formation of Top1cc is a general process of apoptotic cell death induced by anticancer chemotherapeutic agents. We tested the formation of Top1cc during apoptosis induced by topoisomerase II (Top2) and tubulin inhibitors, which by themselves do not directly interact with Top1. Top2 inhibitors initiate apoptosis by trapping Top2 cleavage complexes (Top2cc), thereby generating DNA double-strand breaks (11 -13) . Top2 inhibitors, such as etoposide (VP-16), doxorubicin, and amsacrine (m-AMSA), are among the most potent inducers of apoptosis and are commonly prescribed drugs to treat a variety of cancers (14) . The tubulin inhibitors vinblastine and Taxol (paclitaxel) are anticancer drugs that initiate apoptosis by binding specifically at the interface of the tubulin heterodimer, thereby interfering with microtubule growth (6, 15, 16 ).
The present study shows that VP-16, doxorubicin, m-AMSA, and vinblastine induce Top1cc that form in the early phase of apoptosis and persist throughout the apoptotic process. In response to VP-16, the formation of apoptotic Top1cc is prevented by the caspase inhibitor benzyloxycarbonyl-Val-Ala-DL-Asp(OMe)-fluoromethylketone (Z-VAD-fmk) and the antioxidant N-acetyl-L-cysteine. We propose that the trapping of Top1cc is a general process of apoptotic cell death, which is caused by alterations of the DNA structure (oxidized bases and strand breaks) induced by caspases and reactive oxygen species (ROS).
Materials and Methods
Cell Culture, Drugs, and Chemical Reagents The human leukemia (CEM and HL-60) and colon carcinoma (HCT116) cell lines (American Type Culture Collection, Manassas, VA) were cultured as described (8) . VP-16, doxorubicin, m-AMSA, vinblastine, and N-acetyl-Lcysteine were obtained from Sigma (St. Louis, MO). The caspase peptide inhibitor z-VAD-fmk was obtained from Bachem (Torrance, CA). Taxol (paclitaxel) was a kind gift from Dr. Tito Fojo (National Cancer Institute, NIH, Bethesda, MD). [2- 14 C]thymidine was from Perkin-Elmer Life Sciences (Boston, MA).
Detection of Cellular Topoisomerase Cleavage Complexes
Topoisomerase cleavage complexes were detected using the in vivo complex of enzyme bioassay as described (8, 10, 17) . Briefly, cells were lysed in 1% Sarkosyl and homogenized. The cell lysates were centrifuged on cesium chloride step gradients at 165,000 Â g for 20 h at 20jC. Twenty fractions (0.5 mL) were collected and diluted (v/v) into 25 mmol/L potassium phosphate buffer (pH 6.6). The DNA-containing fractions (fractions 7 -11) were pooled (except in Fig. 1D ) and applied to polivinylidene difluoride membranes (Immobilon-P, Millipore, Billerica, MA) using a slot-blot vacuum manifold. Topoisomerase cleavage complexes were detected by immunoblotting using the C21 Top1 mouse monoclonal antibody (1:1,000 dilution; a kind gift from Dr. Yung-Chi Cheng, Yale University, New Haven, CT) or a Top2a mouse monoclonal antibody (clone Ki-S1; 1:1,000 dilution) from Chemicon International (Temecula, CA).
DNA Fragmentation Assay Apoptotic DNA fragmentation was quantified by filter elution assay as described (18) . Briefly, cells were incubated with [2- 14 C]thymidine (0.02 ACi/mL) for 2 days and chased overnight in radioisotope-free medium. After drug treatment, cells were loaded onto a protein-absorbing filter (Metricel membrane filter, 0.8 Amol/L pore size, 25 mm diameter; Pall Corp., East Hills, NY), washed with PBS, and lysed in 0.2% sodium Sarkosyl, 2 mol/L NaCl, and 0.04 mol/L EDTA (pH 10.0). The filters were then washed with 0.02 mol/L EDTA (pH 10.0). DNA was depurinated by incubation of filters in 1 mol/L HCl at 65jC and then released from the filters with 0.4 mol/L NaOH at room temperature. Radioactivity was counted by liquid scintillation spectrometry in each fraction (wash, lysis, EDTA wash, and filter). DNA fragmentation was measured as the fraction of disintegrations per min in the lysis fraction plus EDTA wash relative to the total intracellular disintegrations per min.
Caspase-3 Activity Caspase-3 activity was measured as described (19) . Briefly, cells were incubated in lysis buffer [150 mmol/L NaCl, 50 mmol/L Tris-HCl (pH 8.0), 0.1% SDS, 1% NP40, Western Blotting Western blotting analyses on whole-cell extracts were done as described (8) using the rabbit antihuman caspase-3 (1:5,000 dilution; BD PharMingen, San Diego, CA) and poly(ADP-ribose) polymerase (1:5,000 dilution; Roche, Indianapolis, IN) antibodies.
Results and Discussion
The Top2 Inhibitors VP-16, Doxorubicin, and m-AMSA Induce Top1cc During Apoptosis Trapped Top1cc and Top2cc can be detected in genomic DNA after cesium chloride gradient centrifugation and immunoblotting with Top1 and Top2 antibodies (8, 10, 17, 20) , respectively. In human leukemia CEM cells exposed to VP-16, we detected high levels of Top1cc (Fig. 1A , middle) with kinetics that coincided with the occurrence of apoptosis measured by DNA fragmentation (Fig. 1A, top) . Apoptotic DNA fragmentation and Top1cc were both detected after 4 h of VP-16 exposure. Similar levels of Top1cc persisted throughout the apoptotic process as most of the cellular DNA became fragmented (Fig. 1A) . The induction of Top1cc induced by VP-16 was coincident with the activation of caspase-3, as shown by the ability of cell lysates to cleave DEVD-AFC, a fluorogenic substrate that mimics the target site of caspase-3 and closely related caspases (Fig. 1B, top) , and the decrease of the 32-kDa proform of caspase-3 with the appearance of its cleaved 19-and 17-kDa active fragments (Fig. 1B, middle) . Kinetics of caspase-3 activation was further confirmed by the caspase-dependent cleavage of poly(ADP-ribose) polymerase (Fig. 1B, bottom) . VP-16-induced Top1cc were also observed in the human colon carcinoma HCT116 cells undergoing apoptosis (Fig. 1C and D) . Thus, the induction of Top1cc by VP-16 can be observed in different human cell types as they undergo apoptosis.
VP-16 is a specific Top2 inhibitor (21) . It is well established that VP-16 does not trap directly Top1cc. Accordingly, short exposure to VP-16 (for up to 2 h) trapped only Top2cc (Fig. 1A, bottom) . However, Top1cc were induced by 4 h of VP-16 exposure (Fig. 1A, middle) . These Top1cc persisted after the removal of VP-16 as cells were committed to apoptosis, whereas trapping of Top2cc was only transient ( Fig. 2A; ref. 21 ). Thus, we conclude that trapping of Top2cc by VP-16 initiates apoptosis and subsequently induces the formation of Top1cc. Consistently, two other Top2 inhibitors, doxorubicin and m-AMSA, also induced Top1cc in apoptotic leukemia HL-60 cells (Fig. 2B) . To further examine the relationship between Top1cc and apoptosis, we investigated whether inactivating the apoptotic pathways would affect the generation of Top1cc by VP-16. Inhibition of apoptotic DNA fragmentation by the caspase peptide inhibitor z-VAD-fmk (Fig. 3, top) prevented the induction of Top1cc by VP-16 (Fig. 3, bottom) . Together, these findings show the appearance of high levels Top1cc in the early phase of apoptosis induced by Top2 inhibitors.
VP-16-Induced Top1cc Are Linked to the Generation of Oxygen Radicals
Because Top1cc can be induced by ROS (22) and oxidative DNA lesions (4, 8 -10) and because VP-16 and doxorubicin generate ROS and oxidative DNA lesions (23, 24) , we tested whether the apoptotic Top1cc induced by Top2 inhibitors resulted from oxidative lesions. Quenching ROS with the antioxidant N-acetyl-L-cysteine prevented VP-16-induced Top1cc and apoptosis (Fig. 3) . Similarly, the induction of apoptotic Top1cc by arsenic trioxide and staurosporine has been shown to involve oxidative DNA lesions (8 -10) . Thus, we propose that Top2 inhibitors induce ROS that produce oxidative DNA lesions (oxidized bases and strand breaks), thereby generating Top1cc in apoptotic cells. These ROS can be generated by permeabilized mitochondria during apoptosis (9) .
The Tubulin Inhibitors Vinblastine and Taxol Also Induce Apoptotic Top1cc
Next, we examined the occurrence of Top1cc during apoptosis induced by the anticancer drugs vinblastine and Taxol, which induce apoptosis following inhibition of microtubule growth (6, 15, 16) . In CEM cells undergoing apoptosis, both vinblastine (Fig. 4A) and Taxol (Fig. 4B ) also induced Top1cc. Inhibition of apoptosis by the caspase inhibitor z-VAD-fmk prevented the formation of Top1cc in vinblastine-treated cells (Fig. 4A) .
Although it has been reported that Top2a participates in chromatin condensation (25) and in the excision of DNA loops (26) during apoptosis, we did not detect Top2cc in apoptotic cells following exposure to vinblastine (Fig. 4C) and Taxol (Fig. 4D) . Similarly, apoptotic Top1cc formed in the absence of Top2cc in response to arsenic trioxide (10) . It is therefore possible that the catalytic activity of Top2a (rather than its stabilization on DNA as Top2cc) contributes to chromatin fragmentation. However, we cannot exclude that the levels of Top2cc formed during apoptosis are below the threshold of detection of our assays.
Conclusion
Altogether, our findings indicate that the formation of Top1cc is a general process of apoptotic cell death. Table 1 summarizes the various agents that have been identified as producing apoptotic Top1cc. In addition to Top2 and by Top2 and tubulin inhibitors. Top2 or tubulin inhibitors initiate apoptosis by activating and producing ROS, which leads to the formation of Top1cc. Top1cc might participate in apoptosis execution by generating DNA strand breaks [1] and by engaging the apoptotic machinery in trans [2] .
tubulin inhibitors, we reported in a meeting abstract (27) the occurrence of Top1cc during apoptosis induced by tumor necrosis factor -related apoptosis ligand, Fas ligand, and the BCL-2 homology domain-3 mimetics antimycin A and BH3I-2 ¶.
1 During the preparation of this article, Rockstroh et al. (28) also reported the formation of apoptotic Top1cc in response to tumor necrosis factor-a and colcemid (Table 1) , and Sen et al. (29) showed the conservation of apoptotic Top1cc in the parasite Leishmania donovani.
The formation of Top1cc depends on caspase activation and ROS. It is well established that caspases activate endonucleases during apoptosis (30) . The DNA breaks produced by apoptotic nucleases, such as CAD/DFF40 and endonuclease G, (30) may contribute to the trapping of Top1cc as Top1 can be directly trapped by DNA breaks (5, 31). In addition, caspases are also involved in the generation of ROS (32, 33) . In fact, z-VAD-fmk prevented VP-16-induced oxidative DNA lesions (23) . Activation of caspases could therefore serve to generate the ROS that lead to apoptotic Top1cc.
It is therefore plausible that Top1, which is ubiquitous in mammalian cells (34) , participates in apoptosis by generating Top1-associated DNA breaks. These breaks may contribute to the cleavage of DNA in high molecular weight fragments (9, 28) . Top1cc could also engage the apoptotic machinery in trans as Top1cc are potent initiators of apoptosis (35) . Apoptotic Top1cc could therefore serve to amplify the apoptotic process engaged by Top2cc and tubulin inhibition (see Fig. 5 ) as well as by a variety of other agents, including arsenic trioxide (10), staurosporine (8, 29) , UV irradiation (7), tumor necrosis factor-a (28), tumor necrosis factor -related apoptosis ligand, Fas ligand, and BCL-2 homology domain-3 mimetics (Table 1; Generation of pyrimidine dimers and 4,6-photoproducts
Abbreviations: TNF-a, tumor necrosis factor; TRAIL, tumor necrosis factor -related apoptosis ligand; DR4, death receptor 4, DR5, death receptor 5; TNFR1, tumor necrosis factor receptor 1; BH3, BCL-2 homology domain-3; PDK1, phosphoinositide-dependent kinase 1; PKC, protein kinase C; Chk1, checkpoint kinase 1; Chk2, checkpoint kinase 2.
